Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Peter G. M. Mol"'
Publikováno v:
British Journal of Clinical Pharmacology. 84:2729-2746
Aims Understanding how much healthcare professionals (HCPs) know about medication can help in devising strategies to improve rational medication use. This study aimed to synthesize information on the level of medication knowledge of HCPs in Africa. M
Autor:
Jeroen Diepstraten, F. Nanne. Croles, Rolf Brouwer, Marieke J. H. A. Kruip, Peter G. M. Mol, Patricia M. L. A. van den Bemt, Esther Kragten, Suzanne Polinder, Albert R Dreijer, Frank W.G. Leebeek
Publikováno v:
PLoS One (print), 15(6 June):e0235048. Public Library of Science
PLoS ONE, Vol 15, Iss 6, p e0235048 (2020)
PLoS ONE, 15(6):e0235048, 1-16. PUBLIC LIBRARY SCIENCE
PLoS ONE
PLoS ONE, Vol 15, Iss 6, p e0235048 (2020)
PLoS ONE, 15(6):e0235048, 1-16. PUBLIC LIBRARY SCIENCE
PLoS ONE
BackgroundAlthough the benefits of antithrombotic drugs are indisputable to reduce thrombotic events, they carry a high risk of compromising patient safety. No previous studies investigated the implementation and (cost-) effectiveness of a hospital-b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a84845e4cdf872028b323206a3796b0b
https://pure.eur.nl/en/publications/ef0d7319-5f2b-4fcc-9e30-97ee327abe4b
https://pure.eur.nl/en/publications/ef0d7319-5f2b-4fcc-9e30-97ee327abe4b
Autor:
Priya Bahri, Mireia Castillon, Xavier Kurz, Kelly Plueschke, Peter G. M. Mol, Daniel Nogueras Zondag, Carla Alonso Olmo, Patricia McGettigan
Publikováno v:
Drug Safety, 42(11), 1343-1351. ADIS INT LTD
Drug Safety
Drug Safety
Introduction Patient registries, ‘organised systems that use observational methods to collect uniform data on a population defined by a particular disease, condition, or exposure, and that is followed over time’, are potentially valuable sources
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c3df2c7bd0ae1ae08b4c82c6a33fcc
https://research.rug.nl/en/publications/e793a2be-794d-4f01-abfb-7e631867151d
https://research.rug.nl/en/publications/e793a2be-794d-4f01-abfb-7e631867151d
Autor:
Emily Freeman, Priya Bahri, Elaine H. Morrato, Andrea M. Russell, Peter G. M. Mol, Sarah Frise, Meredith Smith
Publikováno v:
Drug Safety
Drug Safety, 41(4), 389-401. ADIS INT LTD
Drug Safety, 41(4), 389-401. ADIS INT LTD
Introduction Pharmaceutical risk minimization programs involve interventions designed to support safe and appropriate use of medicines. Currently, information regarding the evaluation of these programs is not publicly reported in a standardized and t
Autor:
Alan Charney, Rajiv Agarwal, Bhupinder Singh, Dahlia Garza, David G. Warnock, Jonathan H. Seltzer, William C. Cushman, Salim Shah, Michael Walsh, Bengt Fellström, Peter G. M. Mol, Bernard Canaud, Nicolas Guzman, Janet Wittes, Faiez Zannad, Christopher S. Wilcox, Jonathan C. Craig, Bergur V. Stefánsson, Frank A. Holtkamp, Amil M. Shah, Gérard M. London, Luis M. Ruilope, Yves Rosenberg, Ron T. Gansevoort, Christoph Wanner, Ziad A. Massy, Gilles Chatellier, Aliza Thompson, Alexandre Mebazaa, Wendy Gattis Stough, Bertram Pitt, Kristian Thygesen, Marc A. Pfeffer, Norman Stockbridge, Patrick Rossignol
Publikováno v:
European Heart Journal, 40(11), 880-887. Oxford University Press
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Rossignol, P, Agarwal, R, Canaud, B, Charney, A, Chatellier, G, Craig, J C, Cushman, W C, Gansevoort, R T, Fellström, B, Garza, D, Guzman, N, Holtkamp, F A, London, G M, Massy, Z A, Mebazaa, A, Mol, P G M, Pfeffer, M A, Rosenberg, Y, Ruilope, L M, Seltzer, J, Shah, A M, Shah, S, Singh, B, Stefánsson, B V, Stockbridge, N, Stough, W G, Thygesen, K, Walsh, M, Wanner, C, Warnock, D G, Wilcox, C S, Wittes, J, Pitt, B, Thompson, A & Zannad, F 2019, ' Cardiovascular outcome trials in patients with chronic kidney disease : Challenges associated with selection of patients and endpoints ', European Heart Journal, vol. 40, no. 11, pp. 880-886 . https://doi.org/10.1093/eurheartj/ehx209
Although cardiovascular disease is a major health burden for patients with chronic kidney disease, most cardiovascular outcome trials have excluded patients with advanced chronic kidney disease. Moreover, the major cardiovascular outcome trials that
Autor:
Sieta T. de Vries, Peter G. M. Mol, Carmen Lasheras Ruiz, Lisa Wong, Alastair G. Sutcliffe, François Houÿez
Publikováno v:
Drug Safety, 40(5), 443-455. ADIS INT LTD
Drug Safety
Drug Safety
Introduction A mobile app may increase the reporting of adverse drug reactions (ADRs) and improve the communication of new drug safety information. Factors that influence the use of an app for such two-way risk communication need to be considered at
Autor:
Petra Denig, Carmen Lasheras Ruiz, Sieta T. de Vries, Peter G. M. Mol, François Houÿez, Lisa Wong, Alastair G. Sutcliffe
Publikováno v:
Drug Safety, 41(7), 697-712. ADIS INT LTD
Previously, an app has been developed for healthcare professionals (HCPs) and patients to report adverse drug reactions (ADRs) to national medicines agencies and to receive drug safety information.This study aimed to assess (1) European HCPs' and pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::204a9cd00c1e14248bd95b7c83cbdb8c
https://research.rug.nl/en/publications/8ba006fd-3db0-42f4-bc48-4ee6fd706f29
https://research.rug.nl/en/publications/8ba006fd-3db0-42f4-bc48-4ee6fd706f29
Autor:
Peter G. M. Mol, Kidanemariam G. M. Beyene, Kristina Star, Derbew Fikadu Berhe, Flora M. Haaijer-Ruskamp, Kristina Juhlin, Katja Taxis, Mukesh Dheda
Publikováno v:
Tropical Medicine & International Health, 20(6), 797-806. Wiley
Background: Many pharmacovigilance centers have been established in Sub Sahara Africa (SSA) in recent years. Their focus has been on ADRs to drugs for communicable diseases. Little is known about ADRs caused by drugs for cardiometabolic diseases, alt
Autor:
Ludo Vandorpe, Willy Peetermans, Hilde Leenaers, Filip Van den Bossche, Pieter-Jan Cortoos, Gert Laekeman, Ludo Willems, Christa Gilissen, Peter G. M. Mol, Steven Simoens
Publikováno v:
Journal of Antimicrobial Chemotherapy, 66(12), 2864-2871. Oxford University Press
Background: Guideline-concordant therapies have been proven to be associated with improved health and economic outcomes in the treatment of community-acquired pneumonia (CAP). However, actual use of CAP guidelines remains poor, but using tailored int
Autor:
Karin M. Vermeulen, Rianne J. Zaal, Patricia M. L. A. van den Bemt, Jasperien E. van Doormaal, Peter G. M. Mol, Jos G. W. Kosterink, Flora M. Haaijer-Ruskamp
Publikováno v:
Journal of Evaluation in Clinical Practice. 16:738-743
Objectives To explore physicians' and nurses' expectations before and experiences after the implementation of a computerized physician order entry (CPOE) system in order to give suggestions for future optimization of the system as well as the impleme